NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

“As long as management has NOT arranged large sums of non dilutive cash or dilutive but against much higher SP we will not appreciate that much after UK approval. I hate to tell you this.”

-Agreed. Also, any spike we get at UK approval will give back most of its gain if large non dilutive cash is not accompanied in parallel. Plus no hiring on the commercial front will make matters worse, if there is no partner to take on GBM sales. Again, the usual pumpers will play the victim card, but the management must be blamed. They have had years to plan for this!